Virginia Retirement Systems Et Al Biocryst Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 113,004 shares of BCRX stock, worth $783,117. This represents 0.01% of its overall portfolio holdings.

Number of Shares

113,004

Previous 83,704 35.0%

Holding current value

$783,117

Previous $749,000 14.42%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$7.55 - $9.06 $221,215 - $265,458	29,300 Added 35.0%	113,004 $857,000
Q2 2025 Jul 29, 2025	BUY	$6.41 - $11.19 $173,070 - $302,130	27,000 Added 47.62%	83,704 $749,000
Q1 2025 Jul 16, 2025	BUY	$7.06 - $9.39 $67,804 - $90,181	9,604 Added 20.39%	56,704 $425,000
Q3 2023 Jan 02, 2024	SELL	$6.71 - $7.92 $224,785 - $265,320	-33,500 Reduced 41.56%	47,100 $333,000
Q2 2023 Aug 22, 2023	BUY	$6.96 - $8.81 $451,704 - $571,769	64,900 Added 413.38%	80,600 $567,000
Q1 2023 Jul 11, 2023	BUY	$7.94 - $11.84 $35,730 - $53,280	4,500 Added 40.18%	15,700 $130,000
Q4 2022 May 17, 2023	BUY	$10.5 - $14.2 $117,600 - $159,040	11,200 New	11,200 $129 Million
Q1 2021 Apr 30, 2021	SELL	$7.37 - $13.61 $77,385 - $142,905	-10,500 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$3.43 - $5.53 $15,092 - $24,332	-4,400 Reduced 29.53%	10,500 $36,000
Q2 2020 Aug 12, 2020	BUY	$1.9 - $5.61 $28,310 - $83,589	14,900 New	14,900 $71,000
Q1 2020 May 12, 2020	SELL	$1.6 - $4.11 $27,040 - $69,459	-16,900 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$1.59 - $3.45 $26,871 - $58,305	16,900 New	16,900 $58,000

Others Institutions Holding BCRX

# of Institutions

314

Shares Held

201M

Call Options Held

930K

Put Options Held

553K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.29B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Biocryst Pharmaceuticals Inc Transaction History